Bayer hits back over Indian complusory licence ruling

March 05, 2013

German pharmaceutical company Bayer says it will appeal yesterday’s decision by India’s IP Appellate Board to uphold a compulsory licence granted over its cancer drug Nexavar

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

More from across our site

Proceed cautiously on SEPs, USPTO warns EU

A senior USPTO attorney spoke at a Nokia-sponsored event on the EU’s proposed SEP Regulation today, November 29

Rory O’Neill, November 29, 2023

Lawyers: India needs major legal reform to cope with deepfakes

IP counsel are ‘flooded’ with queries from clients worried about deepfakes, but the law has so far come up short

Sukanya Sarkar, November 29, 2023

Five minutes with … Charlene Azema, Knobbe Martens

Each week Managing IP speaks to a different IP practitioner about their life and career

Max Walters, November 28, 2023

Cyber security digital file protection. Vector of man using security key to access digital file

Publish the pleadings, law firm tells UPC

Mathys & Squire has filed a test case that the firm hopes will make UPC pleadings available by default

Rory O’Neill, November 28, 2023

View of a crowd with a network of connections. Big data, smart city, wifi concept.

UPC makes long-awaited legal teams fix to CMS

Multiple representatives and their teams can now work on cases using the online CMS, but not everyone can submit documents

Rory O’Neill, November 28, 2023

Behind the case: How Addisons dug in to secure RattleJack victory

James Lawrence, partner at Addisons, explains how he convinced the full Federal Court of Australia to back his client in a patent dispute concerning mining safety equipment

Sukanya Sarkar, November 27, 2023

Sharp and Huawei ink 5G patent cross-licensing deal

The deal will allow the companies to use each other’s patents covering 4G and 5G technologies, and other cellular SEPs

Sukanya Sarkar, November 27, 2023

This week on MIP: Panasonic v Xiaomi, Tupac copyright row

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Rory O’Neill, November 24, 2023

In or out? The perils of picking IP counsel

Three lead IP counsel in the US, the UK and China share how they walk the fine line between building in-house competence and splurging on external lawyers

Sukanya Sarkar, November 23, 2023

Move on up: Mintz IP head talks higher rates and raiding rivals

Mike Renaud, head of the IP division at Mintz, explains his business strategy and how the firm justifies charging higher rates

Rory O’Neill, November 23, 2023